Skip to main content
Search Query
Show Search
Schedule
Main Stream
HD2 Stream
HD3 Stream
Day Sponsors
Main Stream
HD2 Stream
HD3 Stream
Day Sponsors
Programs
Programs A-Z
About Faith
The Better Picture
Bird Calls
Blue Shadows
Conserving Earth
Community Voices
Health Matters
Illuminations
Jazz Out!
Local News Casts
Louisiana Eats!
Regional Symphony
Rhythm Gumbo
Says You!
The Shadow Files
Shreveport House Concerts
What's Bugging You?
Young Artists Competition
Programs A-Z
About Faith
The Better Picture
Bird Calls
Blue Shadows
Conserving Earth
Community Voices
Health Matters
Illuminations
Jazz Out!
Local News Casts
Louisiana Eats!
Regional Symphony
Rhythm Gumbo
Says You!
The Shadow Files
Shreveport House Concerts
What's Bugging You?
Young Artists Competition
NEWS
Red River Radio News
Commentary
Community Voices
All News
NPR News Specials
Red River Radio News
Commentary
Community Voices
All News
NPR News Specials
About Us
About Us
Our Team
Contact Us
Payment / Donation Policy
Community Advisory Board
Audited Financial Reports & EEO Statements
Red River Radio Public Inspection Files
https://www.lsu.edu/bos/index.php
Community Service Report
Employment, Internship and Volunteer Opportunities
CPB Transparency Information
About Us
Our Team
Contact Us
Payment / Donation Policy
Community Advisory Board
Audited Financial Reports & EEO Statements
Red River Radio Public Inspection Files
https://www.lsu.edu/bos/index.php
Community Service Report
Employment, Internship and Volunteer Opportunities
CPB Transparency Information
Underwriting
Event Calendar
Stream Links
© 2026 Red River Radio
Menu
Voice of the Community
Show Search
Search Query
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00
0:00
Available On Air Stations
On Air
Now Playing
Main Channel
On Air
Now Playing
HD 2 All Classical
On Air
Now Playing
HD 3 News/Talk
On Air
Now Playing
HD 4 Alt Red River
All Streams
Schedule
Main Stream
HD2 Stream
HD3 Stream
Day Sponsors
Main Stream
HD2 Stream
HD3 Stream
Day Sponsors
Programs
Programs A-Z
About Faith
The Better Picture
Bird Calls
Blue Shadows
Conserving Earth
Community Voices
Health Matters
Illuminations
Jazz Out!
Local News Casts
Louisiana Eats!
Regional Symphony
Rhythm Gumbo
Says You!
The Shadow Files
Shreveport House Concerts
What's Bugging You?
Young Artists Competition
Programs A-Z
About Faith
The Better Picture
Bird Calls
Blue Shadows
Conserving Earth
Community Voices
Health Matters
Illuminations
Jazz Out!
Local News Casts
Louisiana Eats!
Regional Symphony
Rhythm Gumbo
Says You!
The Shadow Files
Shreveport House Concerts
What's Bugging You?
Young Artists Competition
NEWS
Red River Radio News
Commentary
Community Voices
All News
NPR News Specials
Red River Radio News
Commentary
Community Voices
All News
NPR News Specials
About Us
About Us
Our Team
Contact Us
Payment / Donation Policy
Community Advisory Board
Audited Financial Reports & EEO Statements
Red River Radio Public Inspection Files
https://www.lsu.edu/bos/index.php
Community Service Report
Employment, Internship and Volunteer Opportunities
CPB Transparency Information
About Us
Our Team
Contact Us
Payment / Donation Policy
Community Advisory Board
Audited Financial Reports & EEO Statements
Red River Radio Public Inspection Files
https://www.lsu.edu/bos/index.php
Community Service Report
Employment, Internship and Volunteer Opportunities
CPB Transparency Information
Underwriting
Event Calendar
Stream Links
Search results for
Sort By
Relevance
Newest (Publish Date)
Oldest (Publish Date)
Search
The Strange Alchemy Of Fool's Gold
On their first album, the L.A. band won over fans and critics with their unique blend of African melodies and Hebrew lyrics. They've changed their approach for their latest album, Leave No Trace. Founding members Luke Top and Lewis Pesacov explain why.
Listen
•
7:09
As Drake rules the charts, the 'song of the summer' race heats up
No discussion of the midyear pop charts would be complete without a breakdown of contenders for the honorific "song of the summer."
Listen
•
2:21
Morning news brief
U.S. says it struck another alleged drug-smuggling boat in the eastern Pacific, a judge rules deported Venezuelans be returned to the U.S., top Heritage Foundation officials leaving amid rift in GOP.
Listen
•
11:11
Morning news brief
Facing pressure from world markets President Trump blinks on tariffs, businesses welcome that temporary tariff relief, a former top cybersecurity official is targeted by Trump as a private American.
Listen
•
10:50
Morning news brief
Israel strikes Iran killing two top military leaders, Democratic Sen. Padilla removed from DHS secretary Kristi Noem's press conference, Congress moves to eliminate federal funding for public media.
Listen
•
11:22
Morning news brief
The government will shut down at 12:01 a.m. Wednesday if Congress can't reach a deal, reactions to President Trump's plan to end the war in Gaza, Trump and Hegseth to meet with top military officials.
Listen
•
11:01
From A-To-Z, We Have You Covered For The NCAA March Madness Basketball Tournaments
After the coronavirus led to the cancellation of the NCAA Division 1 basketball tournaments last year, this year's games are on — but with changes including fewer fans, no bands or cheerleaders.
Voters in several states could upend how their elections are run
Voters in a record number of states — including the battlegrounds of Arizona and Nevada — are set to decide this fall whether to enact far-reaching changes to how their elections are run.
Listen
•
3:31
Ex-NFL Player To Draft Picks: 'Your Privacy Is Gone'
Andrew Luck and Robert Griffin III are the top two picks in this year's NFL draft. Former Denver Broncos tight end Nate Jackson knows a thing or two about life in the limelight. He wrote an open letter to Luck and Griffin, and warned them that their "every breath will be a public affair."
Listen
•
4:26
Pfizer to Pay $430 Million Fine over Illegal Marketing
The Pfizer drug company agrees to pay a $430 million fine and plead guilty to illegal marketing practices, U.S. prosecutors say. The unprecedented fine comes after the company admitted that its Warner-Lambert unit promoted Neurontin, an epilepsy drug, for several unapproved uses. The drug remains a top seller for Pfizer, with 2003 sales of $2.7 billion. NPR's Snigdha Prakash reports.
Listen
•
0:00
Previous
467 of 7,725
Next